{"id":435384,"date":"2024-10-28T10:01:17","date_gmt":"2024-10-28T16:01:17","guid":{"rendered":"https:\/\/billieparkernoticias.com\/?p=435384"},"modified":"2024-10-28T10:01:17","modified_gmt":"2024-10-28T16:01:17","slug":"en-el-mes-de-la-lucha-contra-el-cancer-de-mama-cofepris-aprueba-nuevo-tratamiento-para-esta-enfermedad","status":"publish","type":"post","link":"https:\/\/fronteraveracruz.com\/?p=435384","title":{"rendered":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad."},"content":{"rendered":"<ul>\n<li><strong>Capivasertib, en combinaci\u00f3n con fulvestrant, se emplean en el tratamiento de c\u00e1ncer de mama avanzado en personas adultas<\/strong><\/li>\n<li><strong><em>Informe quincenal de ampliaci\u00f3n terap\u00e9utica<\/em>\u00a0reporta la autorizaci\u00f3n de 129 nuevos insumos para la salud en la segunda quincena de septiembre<\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Ciudad de M\u00e9xico, 26 de octubre de 2024.- La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos Sanitarios (Cofepris) autoriz\u00f3 el registro sanitario de capivasertib, un medicamento que, en combinaci\u00f3n con fulvestrant, se utiliza para tratar el c\u00e1ncer de mama avanzado en personas adultas.<\/p>\n<p>Este f\u00e1rmaco contribuye a evitar la multiplicaci\u00f3n de c\u00e9lulas cancerosas y est\u00e1 indicado en pacientes cuyo c\u00e1ncer reapareci\u00f3 o empeor\u00f3 durante o despu\u00e9s de tratamiento con terapia hormonal.<\/p>\n<p>A nivel mundial, el c\u00e1ncer de mama es el tipo m\u00e1s frecuente y la principal causa de muertes por c\u00e1ncer en mujeres. Cerca de 85 por ciento de los casos se presenta en pacientes sin antecedentes familiares de esta enfermedad, por lo que capivasertib contribuye a diversificar las opciones terap\u00e9uticas disponibles para abordar esta grave condici\u00f3n.<\/p>\n<p>Este registro sanitario forma parte de los 16 nuevos medicamentos reportados en el m\u00e1s reciente<u><a href=\"https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/950691\/Informe_de_Ampliaci_n_Terapeutica_30_septiembre_2024.pdf\" target=\"_blank\" rel=\"noopener\">\u00a0<\/a><a href=\"https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/950691\/Informe_de_Ampliaci_n_Terapeutica_30_septiembre_2024.pdf\" target=\"_blank\" rel=\"noopener\"><em>Informe quincenal de ampliaci\u00f3n terap\u00e9utica<\/em><\/a><\/u>\u00a0de Cofepris, correspondiente a la segunda quincena de septiembre.<\/p>\n<p>Entre los insumos para la salud reci\u00e9n registrados se encuentran seis ensayos cl\u00ednicos y 107 dispositivos m\u00e9dicos. De \u00e9stos, 41 se dise\u00f1aron espec\u00edficamente para atenci\u00f3n m\u00e9dica. La lista comprende cat\u00e9teres gu\u00eda, cementos \u00f3seos con antibi\u00f3ticos, cat\u00e9teres angiogr\u00e1ficos, sistemas de pr\u00f3tesis de cadera, injertos sint\u00e9ticos para regeneraci\u00f3n \u00f3sea y periodontal, pr\u00f3tesis de pene, mallas quir\u00fargicas no absorbibles y sistemas de\u00a0<em>stents<\/em>\u00a0coronarios, entre otros.<\/p>\n<p>En el \u00e1mbito del diagn\u00f3stico, se expidieron registros sanitarios a 46 productos, que abarcan kits para la cuantificaci\u00f3n de transcripciones de fusi\u00f3n P210 BCR-ABL1 (B2A2 y B3A2), kits para la cuantificaci\u00f3n de transcripciones de fusi\u00f3n PML-RARA BCR1, BCR2 y BCR3, as\u00ed como pruebas para la determinaci\u00f3n cuantitativa de NT\u2011PROBNP.<\/p>\n<p>Asimismo, esta comisi\u00f3n federal autoriz\u00f3 20 equipos m\u00e9dicos, que incluyen concentradores de ox\u00edgeno, monitores de presi\u00f3n intracraneal, sistemas de diagn\u00f3stico por ultrasonido y l\u00e1seres oft\u00e1lmicos.<\/p>\n<p>La elaboraci\u00f3n y publicaci\u00f3n del\u00a0<em>Informe quincenal de ampliaci\u00f3n terap\u00e9utica<\/em>\u00a0es un ejercicio de transparencia de Cofepris hacia industrias reguladas y pacientes, lo que evidencia el compromiso con la salud y la equidad en el acceso a tratamientos m\u00e9dicos seguros y eficaces para toda la poblaci\u00f3n.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Capivasertib, en combinaci\u00f3n con fulvestrant, se emplean en el tratamiento de c\u00e1ncer de mama avanzado en personas adultas Informe quincenal de ampliaci\u00f3n terap\u00e9utica\u00a0reporta la autorizaci\u00f3n de 129 nuevos insumos para la salud en la segunda quincena de septiembre &nbsp; Ciudad de M\u00e9xico, 26 de octubre de 2024.- La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos&#8230;<\/p>\n","protected":false},"author":1,"featured_media":435386,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","footnotes":""},"categories":[29,18,229],"tags":[4667,183],"class_list":["post-435384","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-las-protagonistas","category-noticias-de-ultima-hora","category-salud","tag-cancer-de-mama","tag-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fronteraveracruz.com\/?p=435384\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz\" \/>\n<meta property=\"og:description\" content=\"Capivasertib, en combinaci\u00f3n con fulvestrant, se emplean en el tratamiento de c\u00e1ncer de mama avanzado en personas adultas Informe quincenal de ampliaci\u00f3n terap\u00e9utica\u00a0reporta la autorizaci\u00f3n de 129 nuevos insumos para la salud en la segunda quincena de septiembre &nbsp; Ciudad de M\u00e9xico, 26 de octubre de 2024.- La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fronteraveracruz.com\/?p=435384\" \/>\n<meta property=\"og:site_name\" content=\"Frontera Veracruz\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-28T16:01:17+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\"},\"headline\":\"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad.\",\"datePublished\":\"2024-10-28T16:01:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384\"},\"wordCount\":452,\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"C\u00e1ncer de mama\",\"Salud\"],\"articleSection\":[\"Las Protagonistas\",\"Noticias de \u00faltima hora\",\"Salud\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384\",\"name\":\"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2024-10-28T16:01:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/?p=435384#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/fronteraveracruz.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#website\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"name\":\"Frontera Veracruz\",\"description\":\"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz\",\"publisher\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fronteraveracruz.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#organization\",\"name\":\"Frontera Veracruz\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"contentUrl\":\"https:\\\/\\\/fronteraveracruz.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/logo-header.png\",\"width\":600,\"height\":220,\"caption\":\"Frontera Veracruz\"},\"image\":{\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/share\\\/1CtNrbq7Bz\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fronteraveracruz.com\\\/#\\\/schema\\\/person\\\/bcc4f8719847e210f67a9030f3486609\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/fronteraveracruz.com\"],\"url\":\"https:\\\/\\\/fronteraveracruz.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fronteraveracruz.com\/?p=435384","og_locale":"es_MX","og_type":"article","og_title":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz","og_description":"Capivasertib, en combinaci\u00f3n con fulvestrant, se emplean en el tratamiento de c\u00e1ncer de mama avanzado en personas adultas Informe quincenal de ampliaci\u00f3n terap\u00e9utica\u00a0reporta la autorizaci\u00f3n de 129 nuevos insumos para la salud en la segunda quincena de septiembre &nbsp; Ciudad de M\u00e9xico, 26 de octubre de 2024.- La Comisi\u00f3n Federal para la Protecci\u00f3n contra Riesgos...","og_url":"https:\/\/fronteraveracruz.com\/?p=435384","og_site_name":"Frontera Veracruz","article_publisher":"https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/","article_published_time":"2024-10-28T16:01:17+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fronteraveracruz.com\/?p=435384#article","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384"},"author":{"name":"admin","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609"},"headline":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad.","datePublished":"2024-10-28T16:01:17+00:00","mainEntityOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384"},"wordCount":452,"publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384#primaryimage"},"thumbnailUrl":"","keywords":["C\u00e1ncer de mama","Salud"],"articleSection":["Las Protagonistas","Noticias de \u00faltima hora","Salud"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/fronteraveracruz.com\/?p=435384","url":"https:\/\/fronteraveracruz.com\/?p=435384","name":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad. - Frontera Veracruz","isPartOf":{"@id":"https:\/\/fronteraveracruz.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384#primaryimage"},"image":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384#primaryimage"},"thumbnailUrl":"","datePublished":"2024-10-28T16:01:17+00:00","breadcrumb":{"@id":"https:\/\/fronteraveracruz.com\/?p=435384#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fronteraveracruz.com\/?p=435384"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/?p=435384#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/fronteraveracruz.com\/?p=435384#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/fronteraveracruz.com\/"},{"@type":"ListItem","position":2,"name":"En el mes de la lucha contra el c\u00e1ncer de mama, Cofepris aprueba nuevo tratamiento para esta enfermedad."}]},{"@type":"WebSite","@id":"https:\/\/fronteraveracruz.com\/#website","url":"https:\/\/fronteraveracruz.com\/","name":"Frontera Veracruz","description":"Noticias C\u00f3rdoba \u00b7 Orizaba \u00b7 Veracruz","publisher":{"@id":"https:\/\/fronteraveracruz.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fronteraveracruz.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/fronteraveracruz.com\/#organization","name":"Frontera Veracruz","url":"https:\/\/fronteraveracruz.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/","url":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","contentUrl":"https:\/\/fronteraveracruz.com\/wp-content\/uploads\/2026\/06\/logo-header.png","width":600,"height":220,"caption":"Frontera Veracruz"},"image":{"@id":"https:\/\/fronteraveracruz.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/share\/1CtNrbq7Bz\/"]},{"@type":"Person","@id":"https:\/\/fronteraveracruz.com\/#\/schema\/person\/bcc4f8719847e210f67a9030f3486609","name":"admin","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ee9bf24b351129017c91674dc617cfdc21c62b9b23a52c046f0b2543ba35355c?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/fronteraveracruz.com"],"url":"https:\/\/fronteraveracruz.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/435384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=435384"}],"version-history":[{"count":0,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=\/wp\/v2\/posts\/435384\/revisions"}],"wp:attachment":[{"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=435384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=435384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fronteraveracruz.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=435384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}